Perfil de Laurus Labs

LAURUSLABS · NSE · INR

₹ 1.971,40Variação em relação ao fechamento anterior: −0,64%Variação absoluta: −₹ 12,60

Fechamento · 5 de outubro de 2026

Perfil da empresa

Laurus Labs tem 7.059 funcionários e sede em Hyderabad, Índia.

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Descrição disponível em inglês.

Dados da empresa

Setor
Saúde
Indústria
Drug Manufacturers - Specialty & Generic
País
Índia
Sede
Jubilee Hills, 500033, Hyderabad
Funcionários
7.059
Listagem
LAURUSLABS · NSE
Moeda
INR